Project Grant HT94252510470
Award Date
9/15/25
Completion Date
9/14/26
Dollars Obligated
$742K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
The University of Alabama at Birmingham (UAB) has been awarded a $6,459,464.00 Project Grant from the Defense Health Agency to evaluate pirfenidone, a novel therapeutic strategy against recurrent acute pancreatitis. The award, which runs from Sep 1, 2023 to Aug 31, 2027, is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research to transform healthcare for Service Members...
The University of Pittsburgh was awarded a $986,228 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a period of performance from June 1, 2025 to May 31, 2029, supports advanced biomedical research aimed at identifying pathways of progression from acute pancreatitis to recurring acute pancreatitis and chronic pancreatitis. This research is expected to contribute to transforming healthcare for military service...
This $1,399,501 federal Project Grant awarded by the Defense Health Agency on September 1, 2023 will fund the development of a novel DNA aptamer-based IFN-γ targeted therapy for chronic cystitis pain at the University of Iowa. The project, which is scheduled for completion by August 31, 2027, aligns with the objectives of the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to transform healthcare for Service Members and the American public through...
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
This $2,428,329 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support The University of Iowa in expanding and accelerating access to care for Achilles tendinopathy through self-management rehabilitation strategies. The funding will enable the university to conduct research and develop innovative solutions to improve treatment outcomes and patient self-care for this medical condition commonly affecting...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $812,487 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to conduct research on "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer". The award period runs from September 30, 2025 to September 29, 2028. The University of Pennsylvania, a leading...
This Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $1,759,708.00 to Iowa State University of Science and Technology to conduct research on high-throughput, high-resolution in vitro models of prostate cancer bone marrow metastases. The award period runs from April 15, 2025 to April 14, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by...
This federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award has a performance period from July 1, 2025 to June 30, 2028 and aims to transform healthcare for military service members, veterans, and the general public through innovative biomedical...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $388,194 to The Johns Hopkins University to conduct research on "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for critical health challenges. The 3-year project, running from...